Ani Pharmaceuticals ANIP
NASDAQ ANIP
$77.91 -0.94 (-1.19%)
At close: Sep 22, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Amortization of Deferred Charges (2014 - 2026)

Ani Pharmaceuticals' (ANIP) quarterly Amortization of Deferred Charges came in at $854000.0 in Q2 2026, up 3.14% year-over-year from $828000.0 in Q2 2025, and up 138.55% quarter-over-quarter from $358000.0 in Q1 2026.

Analysis

Ani Pharmaceuticals (ANIP) Amortization of Deferred Charges (2014 - 2026) Analysis & Trends

Ani Pharmaceuticals has disclosed Amortization of Deferred Charges across 13 years of filings, most recently posting $854000.0 for Q2 2026.

  • In Q2 2026, Amortization of Deferred Charges rose 3.14% year-over-year to $854000.0; the TTM figure through Jun 2026 stood at $2.4 million (up 14.33% YoY), while the FY2025 annual figure was $1.4 million, up 111.21% from the prior year.
  • Amortization of Deferred Charges came in at $854000.0 for Q2 2026 at Ani Pharmaceuticals, up from $358000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $998000.0 in Q4 2022 to a low of $102000.0 in Q1 2024.
  • Average Amortization of Deferred Charges over 5 years is $637611.1, with a median of $591500.0 recorded in 2022.
  • Year-over-year, Amortization of Deferred Charges slumped 89.67% in 2024 and soared 217.65% in 2025.
  • Over 5 years, Amortization of Deferred Charges stood at $998000.0 in 2022, then dropped by 4.61% to $952000.0 in 2023, then sank by 66.07% to $323000.0 in 2024, then climbed by 8.67% to $351000.0 in 2025, then jumped by 143.3% to $854000.0 in 2026.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $854000.0 in Q2 2026, $358000.0 in Q1 2026, and $351000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 854,000.00
Mar 31, 2026 358,000.00
Dec 31, 2025 351,000.00
Sep 30, 2025 838,000.00
Jun 30, 2025 828,000.00
Mar 31, 2025 324,000.00
Dec 31, 2024 323,000.00
Sep 30, 2024 625,000.00
Jun 30, 2024 591,000.00
Mar 31, 2024 102,000.00
Dec 31, 2023 952,000.00
Sep 30, 2023 591,000.00
Jun 30, 2023 591,000.00
Mar 31, 2023 987,000.00
Dec 31, 2022 998,000.00
Sep 30, 2022 592,000.00
Jun 30, 2022 590,000.00
Mar 31, 2022 982,000.00
Dec 31, 2021 794,000.00
Sep 30, 2021 577,000.00
API Access

Ani Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ANIP&period=max&api_key=YOUR_API_KEY